Boston Scientific is buying Penumbra for $14.5 billion to get into the business of removing blood clots
Penumbra’s stock was up about 12% after the deal was announced Thursday morning. www.marketwatch.com #Boston #Scientific #buying #Penumbra #billion #business…
